Rituxan Hycela™ (rituximab and hyaluronidase human) – New drug approval
June 22, 2017 – The FDA announced the approval of Genentech’s Rituxan Hycela (rituximab and hyaluronidase human) for adult patients with various forms of lymphoma and leukemia.
Download PDF
